drugset / Trial / NCT06821594

Role of Intralesional Combined Injection of Furosemide and Digoxin in Cutaneous Warts at Tertiary Care Hospital in Karachi.

NCT06821594

Phase 0 Enrolling by invitation 40 enrolled Jinnah Postgraduate Medical Centre
NaSingle-groupOpen-labelTreatment

Summary

Identify the effects of combined intralesional furosemide 20mg/2ml and digoxin 0.5mg/2ml in cutaneous warts given weekly are rather safe and effective treatment for cutaneous warts, focusing on their effectiveness and safety, at a tertiary care hospital in Karachi, Pakistan.

Timeline

Start
2025-04-01
Primary completion
2025-08-30
Completion
2025-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified Other
Subject Furosemide Other / unclassified Other